The International Partnership for Microbicides today welcomed a positive opinion from the European Medicines Agency on the dapivirine vaginal ring for use by cisgender women ages 18 and older in developing countries to reduce their risk of HIV-1 infection.
from The Medical News https://ift.tt/2WQrex9
from The Medical News https://ift.tt/2WQrex9














Comments
Post a Comment